Business Context and Reporting Period
Company: Evolv Technologies Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2026
Reporting Period: Event-based report regarding legal settlement approval.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a legal settlement.
- Settlement Cost to Company: $0 (No payment required by the Company).
- Attorneys' Fees and Expenses: $1,275,000 (To be paid by the Company's insurers).
Material Changes
The primary material event is the preliminary court approval of a settlement resolving multiple stockholder derivative claims. This resolves:
- Consolidated stockholder derivative action in the U.S. District Court for the District of Massachusetts (Master File No. 1:24-cv-12822-ADB).
- Stockholder derivative actions in the Delaware Court of Chancery (Bersch v. George, et al. and Patrick v. Charlton, et al.).
- A pre-suit litigation demand by stockholder Nicholas R. Ingrao.
As part of the settlement, the Company has agreed to implement certain corporate governance enhancements.
Guidance, Outlook, and Risks
Management Commentary: The settlement fully and finally resolves the identified derivative matters with prejudice. The financial impact is mitigated as the Company's insurers will cover the plaintiffs' attorneys' fees and expenses.
Risks and Contingencies: The filing notes the resolution of pending litigation risks associated with the derivative actions. No new financial risks or guidance updates were provided in this report.
Investor Verification Checklist
- Verify the final approval of the settlement by the Court (currently only preliminary approval is noted).
- Review the specific "corporate governance enhancements" the Company agreed to implement.
- Confirm the insurance coverage details regarding the $1,275,000 payment obligation.
- Access the attached Notice of Pendency (Exhibit 99.1) and Stipulation (Exhibit 99.2) on the Company's Investor Relations website for full legal terms.